[Reprogramming of nuclear proteasomes in K562 cells undergoing apoptosis. II. Effect of anticancer drug doxorubicin]

Tsitologiia. 2007;49(7):552-60.
[Article in Russian]

Abstract

The induction of apoptosis in K562 cells by doxorubicin (DR) was used as a model to investigate changes in the subunit composition, phosphorylation state and enzymatic activities of 26S proteasomes in cells undergoing the programmed death. Here we have shown for the first time that proteasomes isolated from the nuclei of control and induced K562 cells differ in their subunit patterns, as well as in the phosphorylation state of subunits on threonine and tyrosine residues. It has been shown for the first time that trypsin- and chymotrypsin-like, and the endoribonuclease activities of nuclear 26S proteasomes are affected under influence of DR on K562 cells. Treatment of K562 cells with DR leads to modification of zeta/alpha5 and iota/alpha6 proteasomal subunits associated with RNase activity of proteasomes. These findings confirm our hypothesis about so-called reprogramming of nuclear proteasomes population in undergoing apoptosis K562 cells which is manifested by changes in proteasomal composition, phosphorylation state, and enzymatic activities during the programmed cell death.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis*
  • Cell Nucleus / metabolism*
  • Doxorubicin / pharmacology
  • Humans
  • K562 Cells / drug effects
  • K562 Cells / physiology
  • Nuclear Proteins / metabolism
  • Phosphorylation
  • Proteasome Endopeptidase Complex / metabolism*
  • Threonine / metabolism
  • Tyrosine / metabolism

Substances

  • Nuclear Proteins
  • Threonine
  • Tyrosine
  • Doxorubicin
  • Proteasome Endopeptidase Complex
  • ATP dependent 26S protease